Healthcare / Drug Manufacturers - GeneralUpdated 2026-05-10 22:07 UTC

ASX/FRE stock hub

ASX/FRE has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

ASX/FREis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

14.8M

Australian Securities Exchange

Market data

Live price

Current market quote for this ticker.

Current price

ASX/FRE

In the news

Latest news · ASX/FRE

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.9P50 20.4P75 41.2

Trailing P/En/a

P25 14.2P50 19.2P75 35.1

ROE-142.7

P25 -118.7P50 -49.4P75 -1.2

ROIC-86.5

P25 -74.7P50 -33.5P75 0.1

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All ASX/FRE market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

162

Groups with data

Currency

AUD

Showing 162 of 162 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Australia
Country code	AU
Enterprise value	AUD 13.4M
Exchange	Australian Securities Exchange
Financial currency	AUD
First seen	2026-05-10
Industry	Drug Manufacturers - General
Isin	AU0000197352
Last refreshed	2026-05-10
Market cap	AUD 14.8M
Price	AUD 0.05
Price currency	AUD
Sector	Healthcare
Sic	2834
Symbol	asx/FRE
Website	https://firebrickpharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-16.55%
EV Earnings	-5.46x
EV/FCF	-5.94x
EV/Sales	32.56x
FCF yield	-15.21%
P/B ratio	7.64x
P/S ratio	36.05x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	46.96%
Gross Profit	AUD 192,879
Gross Profit Growth	-41%
Gross Profit Growth3 Y	-58.57%
Gross Profit Growth5 Y	53.61%
Net Income	AUD -2.5M
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Pretax Margin	-596.85%
ROA	-72.2
Roa5y	-68.09
ROCE	-122.6
ROE	-142.7
Roe5y	-130.1
ROIC	-86.5

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-21.22%
Cagr3y	-33.26%
EPS Growth Quarters	1
EPS Growth Years	0
Revenue Growth	-63.7x
Revenue Growth Q	-53.18x
Revenue Growth Years	2x
Revenue Growth3 Y	-46.95x
Revenue Growth5 Y	78.68x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	AUD 0.2
Assets	AUD 2.3M
Cash	AUD 1.4M
Current Assets	AUD 2.2M
Current Liabilities	AUD 341,727
Equity	AUD 1.9M
Liabilities	AUD 341,727
Long Term Assets	AUD 119,742
Long Term Liabilities	AUD 0
Net Cash	AUD 1.4M
Net Cash By Market Cap	AUD 9.69
Net Cash Growth	57.49%
Net Debt Equity	AUD -0.74
Tangible Book Value	AUD 1.9M
Tangible Book Value Per Share	AUD 0.01
WACC	9.08

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	6.32
Inventory Turnover	0.5
Net Working Capital	AUD 384,032
Quick ratio	4.31
Working Capital	AUD 1.8M
Working Capital Turnover	AUD 0.28

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-20.58%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-21.21%
200-day SMA	0.06
3Y total return	-70.29%
50-day SMA	0.06
50-day SMA vs 200-day SMA	50under200
All Time High	0.75
All Time High Change	-93.07%
All Time High Date	2022-01-31
All Time Low	0.04
All Time Low Change	44.44%
All Time Low Date	2023-10-09
ATR	0
Beta	0.88
Beta1y	0.25
Beta2y	0.36
Ch YTD	-1.89
High	0.05
High52	0.09
High52 Date	2025-06-10
High52ch	-41.57%
Low	0.05
Low52	0.05
Low52 Date	2025-12-30
Low52ch	4%
Ma50ch	-10.5%
Price vs 200-day SMA	-19.13%
RSI	42.45
RSI Monthly	35.9
RSI Weekly	42.77
Sharpe ratio	-0.24x
Sortino ratio	-0.3
Total Return	-20.58%
Tr YTD	-1.89
Tr1m	-21.21%
Tr1w	-1.89%
Tr3m	-23.53%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	AUD -2.4M
Operating margin	-578.9

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	160,787,368%
Net Borrowing	-3,447
Shares Insiders	28.46%
Shares Out	284,753,985
Shares Qo Q	11.17%
Shares Yo Y	20.58%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	AUD -2.3M
Average Volume	158,603.65x
Bv Per Share	0.01
CAPEX	AUD -16,500
Ch1m	-21.21
Ch1w	-1.89
Ch1y	-21.21
Ch3m	-23.53
Ch3y	-70.29
Ch6m	-18.75
Change	0%
Change From Open	0
Close	0.05
Days Gap	0
Depreciation Amortization	7,417
Dollar Volume	3,120
Earnings Date	2026-05-25
EBIT	AUD -2.4M
EBITDA	AUD -2.4M
EPS	AUD -0.01
F Score	2
FCF	AUD -2.3M
FCF EV Yield	-16.84x
FCF Per Share	AUD -0.01
Financing CF	2,781,261
Fiscal Year End	June
Founded	2,012
Investing CF	-16,500
Is Primary Listing	1
Last Earnings Date	2026-02-16
Last Report Date	2025-12-31
Ma150	0.06
Ma150ch	-16.67%
Ma20	0.06
Ma20ch	-10.34%
Net CF	529,212
Next Earnings Date	2026-05-25
Open	0.05
Ppne	112,748
Price Date	2026-05-08
Ptbv Ratio	7.64
Relative Volume	0.37x
Revenue	410,699x
SBC By Revenue	15.02x
Share Based Comp	61,674
Tr6m	-18.75%
Volume	60,000
Z Score	14.31

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does ASX/FRE pay a dividend?

Capital-return profile for this ticker.

Performance

ASX/FRE stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns ASX/FRE?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+28.5%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+20.6%

Negative means the company is buying back shares.

Technical

ASX/FRE momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

42.4

Neutral momentum band

Price vs 200-day MA

-19.1%

50/200-day relationship not available

Beta (5Y)

0.88

Moves roughly with the market

Sharpe ratio

-0.24

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About ASX/FRE

Hub-level FAQ points readers to the deeper analysis pages.

What is the current asx/FRE stock rating?

asx/FRE is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full asx/FRE analysis?

The full report lives at /stocks/asx/FRE/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for asx/FRE?

The latest report frames asx/FRE around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the asx/FRE page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.